View More Recent Stories

May 9, 2025 09:36AM Natera (NTRA) PT Raised to $200 at TD Cowen Following Sales Beat
May 8, 2025 04:46PM Natera (NTRA) Tops Q1 EPS by 14c, provides guidance
Apr 24, 2025 07:01AM Natera (NTRA) Announces Broad Clinical Launch of Ultra-Sensitive Signatera Genome MRD Test
Mar 17, 2025 06:34AM Increasing unusual put option volume: TKO LW NTRA XLI JNPR KBE
Mar 10, 2025 11:39AM TD Cowen: 'Top 10 Themes Coming Out of 45th Annual Health Care Conference'
Mar 10, 2025 08:07AM Natera (NTRA) Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer
Feb 28, 2025 09:51AM TD Cowen on Natera (NTRA): '2025 Guide Hits on Many Fronts, Setting Up for Another Strong Year'
Feb 28, 2025 06:53AM Natera (NTRA) PT Raised to $195 at Canaccord Genuity
Feb 27, 2025 04:30PM Natera (NTRA) Tops Q4 EPS by 8c, provides guidance
Feb 25, 2025 06:01AM Natera (NTRA) Announces Medicare Coverage of Signatera for Surveillance in Lung Cancer
Feb 10, 2025 09:47AM Canaccord Genuity Reiterates Buy Rating on Natera (NTRA)
Feb 10, 2025 08:23AM Raymond James Reiterates Outperform Rating on Natera (NTRA)
Jan 27, 2025 09:52AM Canaccord Genuity Reiterates Buy Rating on Natera (NTRA)
Jan 23, 2025 07:50AM Barclays Starts Natera (NTRA) at Overweight
Dec 17, 2024 08:01AM Natera (NTRA): Court Grants Natera’s Request to Include Additional Patent in its Lawsuit Against NeoGenomics
Dec 16, 2024 08:54AM Natera (NTRA) PT Raised to $195 at TD Cowen; 'Solid Momentum Set to Continue'
Nov 30, 2024 04:00AM Is Trump 2.0 good or bad for healthcare stocks?
Nov 25, 2024 03:51PM Natera (NTRA) Issues Statement on Guardant Health Litigation
Nov 18, 2024 07:46AM Natera (NTRA) PT Raised to $200 at Piper Sandler
Nov 13, 2024 11:13AM Natera (NTRA) PT Raised to $175 at TD Cowen
Nov 13, 2024 08:16AM Natera (NTRA) PT Raised to $160 at Baird
Nov 13, 2024 07:35AM Natera (NTRA) PT Raised to $182 at Jefferies
Nov 12, 2024 04:26PM Natera (NTRA) Tops Q3 EPS by 31c, Beats on Revenue; Offers FY24 Revenue Guidance
Nov 12, 2024 04:20PM Natera (NTRA) Tops Q3 EPS by 31c; raises outlook
Oct 29, 2024 06:35AM Natera (NTRA) PT Raised to $150 at Canaccord Genuity
Sep 23, 2024 04:06PM Natera (NTRA) Reports Court Ordered Permanent Injunction Against NeoGenomics' Accused RaDaR Assay
Sep 13, 2024 07:25AM Piper Sandler Reiterates Overweight Rating on Natera (NTRA)
Sep 10, 2024 08:28AM TD Cowen Reiterates Buy Rating on Natera (NTRA)
Sep 10, 2024 07:25AM Canaccord Genuity Reiterates Buy Rating on Natera (NTRA)
Aug 27, 2024 06:32AM Natera (NTRA) PT Raised to $145 at Canaccord Genuity
Aug 9, 2024 02:09PM Natera (NTRA) PT Raised to $145 at TD Cowen
Aug 9, 2024 07:07AM Natera (NTRA) PT Raised to $120 at Baird
Aug 8, 2024 04:39PM Natera (NTRA) Tops Q2 EPS by 39c, provides guidance
Aug 5, 2024 12:12PM TD Cowen Reiterates Buy Rating on Natera (NTRA)
Jul 25, 2024 08:13AM Piper Sandler Reiterates Overweight Rating on Natera (NTRA)
Jul 24, 2024 11:00PM These stocks offer you exposure to rising demand for fertility treatment – Barclays
Jun 27, 2024 07:03AM Natera (NTRA) Announces DECIPHER Phase 2 Trial
Jun 25, 2024 06:17AM Wolfe Research Reiterates Outperform Rating on Natera (NTRA)
Apr 2, 2024 01:00PM Cabot Wealth shares top 10 stocks picks for this week
View More Recent Stories